ESC 365 - When to use cardiovascular magnetic resonance in patients receiving chemotherapy?

ESC Professional Premium Access

When to use cardiovascular magnetic resonance in patients receiving chemotherapy?

Session: Meet the Experts: use of multimodality imaging to evaluate cardiotoxicity: when and how?

Topic: Cross-Modality and Multi-Modality Imaging Topics

Speaker: Professor A. Barac (Falls Church, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Ana Barac

Inova Schar Heart and Vascular, Falls Church (United States of America)

7 presentations

0 follower

3 more presentations in this session

Role of echocardiography in patients receiving chemotherapy: when and which parameters should be used?

Speaker: Professor R. Jurcut (Bucharest, RO)

Computed tomography in patients with late effects of radiotherapy.

Speaker: Doctor G. Gulati (Oslo, NO)

Putting it all together: use of multimodality imaging to evaluate cardiotoxicity: when and how?

Speaker: Associate Professor J. Plana (Houston, US)

Access the full session

Meet the Experts: use of multimodality imaging to evaluate cardiotoxicity: when and how?

Speakers: Professor A. Barac, Professor R. Jurcut, Doctor G. Gulati, Associate Professor J. Plana

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources